Pojasek Kevin, Raman Rahul, Kiley Patrick, Venkataraman Ganesh, Sasisekharan Ram
Division of Bioengineering and Environmental Health, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
J Biol Chem. 2002 Aug 23;277(34):31179-86. doi: 10.1074/jbc.M201552200. Epub 2002 Jun 12.
Chondroitinase B from Flavobacterium heparinum is the only known lyase that cleaves the glycosaminoglycan, dermatan sulfate (DS), as its sole substrate. A recent co-crystal structure of chondroitinase B with a disaccharide product of DS depolymerization has provided some insight into the location of the active site and suggested potential roles of some active site residues in substrate binding and catalysis. However, this co-crystal structure was not representative of the actual enzyme-substrate complex, because the disaccharide product did not have the right length or the chemical structure of the minimal substrate (tetrasaccharide) involved in catalysis. Therefore, only a limited picture of the functional role of active site residues in DS depolymerization was presented in previous structural studies. In this study, by docking a DS tetrasaccharide into the proposed active site of the enzyme, we have identified novel roles of specific active site amino acids in the catalytic function of chondroitinase B. Our conformational analysis also revealed a unique, symmetrical arrangement of active site amino acids that may impinge on the catalytic mechanism of action of chondroitinase B. The catalytic residues Lys-250, Arg-271, His-272, and Glu-333 along with the substrate binding residues Arg-363 and Arg-364 were mutated using site-directed mutagenesis, and the kinetics and product profile of each mutant were compared with recombinant chondroitinase B. Mutating Lys-250 to alanine resulted in inactivation of the enzyme, potentially attributable to the role of the residue in stabilizing the carbanion intermediate formed during enzymatic catalysis. The His-272 and Glu-333 mutants showed diminished enzymatic activity that could be indicative of a possible role for one or both residues in the abstraction of the C-5 proton from the galactosamine. In addition, the Arg-364 mutant had an altered product profile after exhaustive digestion of DS, suggesting a role for this residue in defining the substrate specificity of chondroitinase B.
来自肝素黄杆菌的软骨素酶B是唯一已知的以糖胺聚糖硫酸皮肤素(DS)作为唯一底物的裂解酶。最近,软骨素酶B与DS解聚二糖产物的共晶体结构为活性位点的位置提供了一些见解,并表明了一些活性位点残基在底物结合和催化中的潜在作用。然而,这种共晶体结构并不代表实际的酶-底物复合物,因为二糖产物没有催化过程中涉及的最小底物(四糖)的正确长度或化学结构。因此,在先前的结构研究中,活性位点残基在DS解聚中的功能作用的描述有限。在本研究中,通过将DS四糖对接至该酶的推测活性位点,我们确定了特定活性位点氨基酸在软骨素酶B催化功能中的新作用。我们的构象分析还揭示了活性位点氨基酸独特的对称排列,这可能会影响软骨素酶B的催化作用机制。使用定点诱变对催化残基赖氨酸-250、精氨酸-271、组氨酸-272和谷氨酸-333以及底物结合残基精氨酸-363和精氨酸-364进行突变,并将每个突变体的动力学和产物谱与重组软骨素酶B进行比较。将赖氨酸-250突变为丙氨酸导致酶失活,这可能归因于该残基在稳定酶催化过程中形成的碳负离子中间体方面的作用。组氨酸-272和谷氨酸-333突变体的酶活性降低,这可能表明这两个残基中的一个或两个在从半乳糖胺中提取C-5质子方面可能发挥作用。此外,精氨酸-364突变体在DS彻底消化后的产物谱发生了变化,表明该残基在定义软骨素酶B的底物特异性方面发挥作用。